Satya Allaparthi, MD
Gastroenterology · Castro Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 4 carriers
- Offices
- 2
- Since medical school
- 28 years
- Graduated 1998
Offices
2 locations · Gastroenterology Specialists Medical Group Inc A Medical Corporation · Permanente Medical Group Inc
Hospitals listed: Eden Medical Center. That is not proof they admit you there this week.
Plans that list them
17 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Allaparthi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A156485 · Current
Licensed to practise in California · since 2018 · expires 2027-07-31 · Ntr University of Health Sciences, Vijayawada, Andhra Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$102,018
Medicare paid this office $102,018 for 319 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 132 | $16,923 | $82 |
| Imaging of digestive tract done from the inside of the digestive tract | 17 | $13,028 | $420 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 51 | $11,377 | $223 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $6,872 | $72 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 52 | $5,744 | $104 |
See all 16 services
| Short return visit (20+ min) | 132 | $16,923 | $82 |
| Imaging of digestive tract done from the inside of the digestive tract | 17 | $13,028 | $420 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 51 | $11,377 | $223 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $6,872 | $72 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 52 | $5,744 | $104 |
| New patient visit (30+ min) | 57 | $5,567 | $98 |
| Short return visit | 77 | $5,083 | $52 |
| New patient visit (45+ min) | 33 | $4,907 | $149 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,853 | $118 |
| Return visit (30+ min) | 27 | $3,836 | $113 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,824 | $202 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,474 | $108 |
| Biopsy of large bowel using a flexible endoscope | 18 | $2,454 | $136 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,425 | $152 |
| Diagnostic exam of anus using an endoscope | 11 | $1,275 | $116 |
| New patient visit (15+ min) | 16 | $1,011 | $63 |
Procedures Medicare counted
| Colonoscopy | 76 | More than 73% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 100 | More than 77% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 58 | 20 | 49 | 53 | 49 | 51 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | 17 | 35 | 43 | 38 | 55 |
| Biopsy of large bowel using a flexible endoscope | 44 | 12 | 19 | 26 | 21 | 18 |
| Removal of external hemorrhoids by rubber banding | – | – | – | 34 | 27 | – |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | – | 14 | – | 12 | – |
| Diagnostic exam of large bowel using a flexible endoscope | – | – | – | 14 | – | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
319 Original Medicare patients in 2024. Average age 73 · Under 65 12% · 85 and older 10% · Women 53% · Also on Medicaid 37% · Health risk score 1.69. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 41% · Chronic kidney disease 36% · Coronary heart disease 25% · Depression 24% · Heart failure 22% · COPD 16% · Cancer 15% · Atrial fibrillation 13% · Stroke 13% · Dementia 9%.
The office billed $273,708, Medicare allowed $131,240 and paid $102,018; for 859 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 319 | 859 | 73 | 1.69 | $273,708 | $102,018 |
| 2023 | 320 | 819 | 73 | 1.75 | $271,785 | $97,524 |
| 2022 | 296 | 794 | 74 | 1.66 | $270,310 | $98,184 |
| 2021 | 313 | 842 | 74 | 1.80 | $259,460 | $95,693 |
| 2020 | 178 | 430 | 74 | 1.94 | $113,110 | $39,483 |
| 2019 | 447 | 1,108 | 73 | 1.84 | $337,235 | $126,510 |
| 2018 | 408 | 766 | 73 | 1.82 | $431,795 | $81,689 |
| 2017 | 168 | 325 | 72 | 2.10 | $220,075 | $33,282 |
| 2016 | 64 | 89 | 72 | 2.40 | $12,186 | $6,496 |
| 2015 | 112 | 185 | 74 | 2.44 | $31,535 | $13,541 |
| 2014 | 65 | 108 | 78 | 2.19 | $33,217 | $7,469 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Short return visit (20+ min) | 107 | $12,234 | $75 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $11,274 | $230 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $10,001 | $385 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $9,079 | $71 |
| Removal of external hemorrhoids by rubber banding | 11 | $7,713 | $286 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 52 | $6,093 | $117 |
| New patient visit (30+ min) | 53 | $4,709 | $89 |
| New patient visit (45+ min) | 28 | $4,271 | $153 |
| Return visit (30+ min) | 33 | $3,598 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 36 | $3,267 | $86 |
| Biopsy of large bowel using a flexible endoscope | 21 | $2,880 | $137 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,687 | $207 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,160 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,042 | $107 |
| Short return visit | 52 | $1,979 | $34 |
| New patient visit (15+ min) | 28 | $1,253 | $45 |
2022: 15 services
| Imaging of digestive tract done from the inside of the digestive tract | 19 | $14,822 | $412 |
| Short return visit (20+ min) | 108 | $12,168 | $73 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 52 | $11,997 | $226 |
| Removal of external hemorrhoids by rubber banding | 14 | $9,665 | $284 |
| Return visit (30+ min) | 58 | $7,050 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $6,535 | $63 |
| New patient visit (30+ min) | 62 | $5,943 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $5,228 | $119 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $4,107 | $96 |
| Biopsy of large bowel using a flexible endoscope | 26 | $3,505 | $135 |
| New patient visit (45+ min) | 24 | $3,416 | $142 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,220 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $1,893 | $90 |
| Short return visit | 37 | $1,573 | $40 |
| New patient visit (15+ min) | 18 | $828 | $46 |
2021: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 92 | $11,688 | $64 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $11,059 | $461 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 49 | $10,754 | $219 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 75 | $9,092 | $121 |
| Short return visit (20+ min) | 94 | $8,642 | $69 |
| Return visit (30+ min) | 61 | $6,993 | $101 |
| New patient visit (30+ min) | 50 | $4,838 | $97 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,348 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $2,955 | $92 |
| New patient visit (45+ min) | 20 | $2,669 | $133 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $2,545 | $182 |
| Biopsy of large bowel using a flexible endoscope | 19 | $2,282 | $120 |
| New patient visit (15+ min) | 27 | $1,664 | $62 |
| Short return visit | 33 | $1,496 | $39 |
2020: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $5,982 | $65 |
| Short return visit (20+ min) | 73 | $4,975 | $53 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $4,633 | $232 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,554 | $123 |
| New patient visit (30+ min) | 29 | $1,934 | $67 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,645 | $97 |
| Return visit (30+ min) | 15 | $1,323 | $88 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,178 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,126 | $94 |
| Short return visit | 12 | $299 | $25 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 19 | $269 | $12 |
| New patient visit (15+ min) | 11 | $240 | $22 |
2019: 15 services
| Imaging of digestive tract done from the inside of the digestive tract | 19 | $17,255 | $908 |
| Short return visit (20+ min) | 152 | $14,261 | $64 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 58 | $13,233 | $228 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 107 | $13,134 | $64 |
| New patient visit (30+ min) | 122 | $10,888 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 86 | $10,311 | $119 |
| Biopsy of large bowel using a flexible endoscope | 44 | $6,693 | $152 |
| Return visit (30+ min) | 55 | $5,979 | $89 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 54 | $4,994 | $89 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $3,774 | $199 |
| New patient visit (15+ min) | 64 | $3,765 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $2,851 | $92 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $2,747 | $183 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,724 | $210 |
| Short return visit | 13 | $561 | $43 |
2018: 14 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 117 | $13,592 | $115 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 45 | $10,283 | $224 |
| New patient visit (45+ min) | 75 | $9,106 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $6,835 | $62 |
| Long return visit (40+ min) | 40 | $5,028 | $114 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $4,396 | $88 |
| New patient visit (30+ min) | 30 | $3,006 | $100 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $2,794 | $140 |
| Return visit (30+ min) | 31 | $2,725 | $85 |
| Biopsy of large bowel using a flexible endoscope | 21 | $2,557 | $122 |
| New patient visit (15+ min) | 18 | $1,272 | $71 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,231 | $88 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 45 | $207 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 11 | $33 | $3 |
2017: 9 services
| New patient visit (45+ min) | 47 | $6,114 | $130 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,341 | $111 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 15 | $3,217 | $214 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $3,011 | $58 |
| Long return visit (40+ min) | 16 | $1,805 | $113 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 11 | $1,349 | $123 |
| Return visit (30+ min) | 14 | $1,325 | $88 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $992 | $55 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 23 | $100 | $4 |
2016: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,596 | $58 |
2015: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $5,770 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,683 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,955 | $163 |
| Hospital discharge day management, more than 30 minutes | 20 | $1,640 | $82 |
2014: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $4,150 | $58 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,117 | $86 |
Medicaid work
$3,853 in 2018
Medicaid paid $3,853 for 88 billed services this clinician did in 2018, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 59 | $3,154 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 29 | $698 |
| 2018 | 88 | 2 | 17 | $3,853 |
Drugs they prescribed that Part D paid
$206,943
Pharmacies billed $206,943 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 606) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
494 generic and fewer than 11 brand-name prescriptions · $206,943 in drug cost · 36 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 16 | $14,585 | $912 |
| Sod Sulf-Potass Sulf-Mag Sulf | 139 | $8,241 | $59 |
| Sucralfate | 13 | $2,339 | $180 |
| Pantoprazole | 187 | $1,988 | $11 |
| Cholestyramine | 12 | $1,159 | $97 |
See all 9 drugs
| Linzess | 16 | $14,585 | $912 |
| Sod Sulf-Potass Sulf-Mag Sulf | 139 | $8,241 | $59 |
| Sucralfate | 13 | $2,339 | $180 |
| Pantoprazole | 187 | $1,988 | $11 |
| Cholestyramine | 12 | $1,159 | $97 |
| Lactulose | 26 | $838 | $32 |
| Peg 3350-Electrolyte | 28 | $512 | $18 |
| Famotidine | 35 | $472 | $13 |
| Hydrocortisone | 12 | $321 | $27 |
Year by year
| 2024 | 606 | 289 | 0% (0) | None | $206,943 |
| 2023 | 503 | 246 | 0% (0) | 25% | $161,564 |
| 2022 | 448 | 201 | 0% (0) | 27% | $70,548 |
| 2021 | 347 | 165 | 0% (0) | 35% | $34,938 |
| 2020 | 367 | 157 | 0% (0) | 28% | $63,205 |
| 2019 | 545 | 224 | 0% (0) | 45% | $153,129 |
| 2018 | 256 | 145 | 0% (0) | 36% | $211,238 |
| 2017 | 175 | 66 | None | 13% | $11,664 |
| 2016 | 90 | 34 | None | 28% | $14,501 |
| 2015 | 88 | 30 | None | 30% | $15,485 |
| 2014 | 28 | 16 | None | None | $3,522 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Linzess | 15 | $16,219 | $1,081 |
| Sod Sulf-Potass Sulf-Mag Sulf | 105 | $8,040 | $77 |
| Pantoprazole | 148 | $2,357 | $16 |
| Sucralfate | 12 | $2,323 | $194 |
| Mesalamine | 15 | $1,537 | $102 |
| Peg 3350-Electrolyte | 31 | $655 | $21 |
| Gavilyte-C | 24 | $418 | $17 |
| Famotidine | 22 | $356 | $16 |
| Lactulose | 12 | $282 | $23 |
| Gabapentin | 12 | $61 | $5 |
2022: 7 drugs
| Linzess | 14 | $9,289 | $664 |
| Suprep | 58 | $6,712 | $116 |
| Sod Sulf-Potass Sulf-Mag Sulf | 18 | $1,454 | $81 |
| Pantoprazole | 138 | $1,400 | $10 |
| Sucralfate | 19 | $1,396 | $73 |
| Peg 3350-Electrolyte | 32 | $546 | $17 |
| Gavilyte-C | 26 | $404 | $16 |
2021: 7 drugs
| Suprep | 65 | $7,177 | $110 |
| Sucralfate | 15 | $1,080 | $72 |
| Budesonide Dr | 11 | $1,034 | $94 |
| Pantoprazole | 92 | $887 | $10 |
| Gavilyte-C | 16 | $215 | $13 |
| Peg 3350-Electrolyte | 13 | $178 | $14 |
| Famotidine | 14 | $121 | $9 |
2020: 10 drugs
| Creon | 12 | $12,328 | $1,027 |
| Mesalamine | 20 | $3,255 | $163 |
| Suprep | 26 | $2,826 | $109 |
| Ursodiol | 15 | $2,339 | $156 |
| Mesalamine Er | 11 | $2,319 | $211 |
| Sucralfate | 29 | $1,900 | $66 |
| Cholestyramine | 14 | $821 | $59 |
| Gavilyte-C | 36 | $651 | $18 |
| Pantoprazole | 72 | $541 | $8 |
| Famotidine | 11 | $89 | $8 |
2019: 12 drugs
| Suprep | 106 | $10,579 | $100 |
| Linzess | 19 | $8,004 | $421 |
| Mesalamine | 11 | $6,361 | $578 |
| Apriso | 12 | $3,660 | $305 |
| Cholestyramine | 23 | $2,840 | $123 |
| Moviprep | 26 | $2,796 | $108 |
| Budesonide Ec | 17 | $2,510 | $148 |
| Sucralfate | 51 | $1,825 | $36 |
| Pantoprazole | 112 | $1,476 | $13 |
| Polyethylene Glycol 3350 | 11 | $655 | $60 |
| Omeprazole | 21 | $294 | $14 |
| Famotidine | 14 | $89 | $6 |
2018: 7 drugs
| Suprep | 42 | $4,014 | $96 |
| Polyethylene Glycol 3350 | 14 | $680 | $49 |
| Omeprazole | 28 | $471 | $17 |
| Sucralfate | 17 | $438 | $26 |
| Gavilyte-G | 25 | $310 | $12 |
| Pantoprazole | 22 | $182 | $8 |
| Ranitidine | 18 | $110 | $6 |
2017: 5 drugs
| Polyethylene Glycol 3350 | 15 | $657 | $44 |
| Gavilyte-G | 20 | $240 | $12 |
| Omeprazole | 26 | $153 | $6 |
| Ranitidine | 27 | $130 | $5 |
| Warfarin | 17 | $43 | $3 |
2016: 2 drugs
| Pantoprazole | 12 | $191 | $16 |
| Dicyclomine | 11 | $132 | $12 |
2015: 2 drugs
| Pantoprazole | 18 | $150 | $8 |
| Ciprofloxacin | 12 | $37 | $3 |
Money from drug and device companies
$500 in 2020
A payment is not proof that care is biased.
| CapsoPro Services | None | $500 | 1 payment
|
See the published payment
| CapsoPro Services | Consulting · 2020-05-06 | None | $500 |
Checkups this office reported
16 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 83.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 30%That's less than half. | 376 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 26%That's less than half. | 210 |
| Breast cancer screeningEligible women who got a mammogram | 2%That's few of the people this applied to. | 265 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 28%That's less than half. | 258 |
| Checked for fall riskOlder patients screened for fall risk | 5%That's few of the people this applied to. | 375 |
| Colon cancer screeningEligible adults who got a colon cancer test | 72%That's more than half. | 601 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 4%That's few of the people this applied to. | 881 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 1%That's few of the people this applied to. | 92 |
See the other 8 measures
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 86%That's most of the people this applied to. Worse on this measure. | 92 |
| Medications listed in the chartVisits where the current medication list was documented | 12%That's few of the people this applied to. | 1,608 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 33%That's less than half. | 937 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 99%That's most of the people this applied to. | 1,337 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 2%That's few of the people this applied to. Better on this measure. | 406 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 7% | 1,034 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 67%That's more than half. | 148 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 22%That's few of the people this applied to. | 927 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Implementation of improvements that contribute to more timely communication of test results
- Implementation of medication management practice improvements
- Implementation of methodologies for improvements in longitudinal care management for high risk patients
- Improved the patient portal
- Lets patients read their visit notes
- Measurement and improvement at the practice and panel level
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Uses standard treatment protocols
- Exempt from immunization registry reporting
Professional record
- NPI
- 1699960815
- Licence
- CA A156485, MA 246459California A156485: Current · expires 2027-07-31
- Group
- Gastroenterology Specialists Medical Group Inc A Medical Corporation · Permanente Medical Group Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 19845 Lake Chabot Rd Ste 104, Castro Valley, CA, 94546
- NPI first listed
- 2007-09-11
- NPI last updated
- 2024-02-15
- NPI record certified
- 2024-02-15
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.